TrialJCI insight2026

NAD+ augmentation by nicotinamide riboside engages SLIT2/ROBO1 signaling to attenuate Th17 inflammation in psoriasis.

Kim Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.